ImmunoGen, Inc.
IMGNDelisted Feb 12, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000855654
ImmunoGen, Inc. was delisted on Feb 12, 2024; its insiders filed their last Form 4 on Feb 12, 2024; 327 institutions reported holding it in 13F filings for Q4 2023, worth $7.54B in total; Maverick Capital was the only superinvestor holding it.
Q3 2023 vs. Q2 2023
How the institutions holding ImmunoGen, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Of which not filed for Q3 2023 | Q3 2023 | Change |
|---|---|---|---|---|
| Holders | 266 | 2 | 276 | +12 |
| Shares | 224.8M | 746.1K | 245.8M | +21.7M (+9.7%) |
| Value | $4.24B | $14.1M | $3.91B | −$313.0M (−7.4%) |
2 institutions that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (46)
Institutions that held ImmunoGen, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
Sold out (34)
Institutions that held ImmunoGen, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
Not filed for Q3 2023 yet (2)
Institutions that held ImmunoGen, Inc. at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Pictet Asset Management SA | 721,075 | $13.6M |
| BFT Financial Group, LLC | 25,000 | $471.8K |